6,018 filings
6-K
GSK
GSK Plc
24 Apr 24
Us Fda Accepts New Indication Filing for Jemperli
6:45am
6-K
GSK
GSK Plc
19 Apr 24
Director/pdmr Shareholding
10:56am
6-K
GSK
GSK Plc
17 Apr 24
Director/pdmr Shareholding
10:52am
6-K
GSK
GSK Plc
17 Apr 24
Results from Long-term Data Relating to Shingrix
6:12am
6-K
GSK
GSK Plc
17 Apr 24
GSK Announces Additional EAGLE-1 Results
6:07am
6-K
d6bq42apbemc tt0fw
16 Apr 24
Amendment - Director/pdmr Shareholding
9:49am
6-K
9el tmdthfg4wmyq7v
16 Apr 24
Fda Accepts GSK Meningitis Vaccine Candidate File
6:20am
6-K
9yas737tqx2ba80jo6
15 Apr 24
Director/pdmr Shareholding
11:26am
6-K/A
e7ppt5dewz3 vy8henmo
4 Apr 24
Replacement - Total Voting Rights
7:46am
6-K
gqfo3sl5fxcoq
2 Apr 24
Total Voting Rights
1:17pm
SC 13D/A
gz7vt1znpkq4u6
28 Mar 24
Nkarta / GSK ownership change
5:06pm
6-K
z2bh5a
26 Mar 24
Director/pdmr Shareholding
7:45am
F-3ASR
ftrka pvd9
25 Mar 24
Automatic shelf registration (foreign)
2:01pm
6-K
bspfar96gi 94dr
25 Mar 24
Notice of Agm
9:38am
6-K
qvyb5h 9w81q5cyzr
22 Mar 24
Transfer of Treasury Shares
12:48pm
6-K
x98ro3o vmw0
22 Mar 24
Director/pdmr Shareholding
12:17pm
6-K
p7006v8yjaslr1ncm7i
18 Mar 24
New Phase III Jemperli Data In Endometrial Cancer
9:56am
6-K
slj64depc180ig ab
13 Mar 24
Director/pdmr Shareholding
1:15pm
6-K
7ss55
8 Mar 24
Board Committee Change
12:48pm
6-K
somcu4kg
7 Mar 24
GSK Announces Positive Blenrep DREAMM-8 Results
6:13am